[Skip to Content]
[Skip to Content Landing]

Year

Day

December 12, 2018
Original Investigation

Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery DiseaseInsights From the EUCLID Trial

Abstract Full Text
free access
JAMA Cardiol. Published online December 12, 2018. doi:10.1001/jamacardio.2018.4171

This analysis of data from the EUCLID trial characterizes the incidence and types of myocardial infarction in patients with peripheral artery disease, identifies factors associated with myocardial infarction, and determines the association of myocardial infarction with cardiovascular mortality and acute limb ischemia.

Brief Report

Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With EvolocumabAn Analysis of FOURIER Trial Data

Abstract Full Text
JAMA Cardiol. Published online December 12, 2018. doi:10.1001/jamacardio.2018.4178

This study evaluates the interindividual variability in low-density lipoprotein cholesterol reduction with the PCSK9 inhibitor drug evolocumab.

December 5, 2018
Original Investigation

Association of Hospital Surgical Aortic Valve Replacement Quality With 30-Day and 1-Year Mortality After Transcatheter Aortic Valve Replacement

Abstract Full Text
JAMA Cardiol. Published online December 5, 2018. doi:10.1001/jamacardio.2018.4051

This national cohort study assesses the quality of hospital outcomes by determining the correlation between mortality after surgical aortic valve replacement procedures and mortality at 30 days and 1 year after transcathether aortic valve replacement procedures.

Invited Commentary

Has a New Determinant of Transcatheter Aortic Valve Replacement Outcomes Been Identified?

Abstract Full Text
JAMA Cardiol. Published online December 5, 2018. doi:10.1001/jamacardio.2018.4170
Review

Durability Data for Bioprosthetic Surgical Aortic ValveA Systematic Review

Abstract Full Text
JAMA Cardiol. Published online December 5, 2018. doi:10.1001/jamacardio.2018.4045

This systematic review analyzes available data on structural valve deterioration of surgical bioprosthetic aortic valves by examining the published literature as well as data reported to the US Food and Drug Administration.

×